Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
Supernus Pharmaceuticals celebrates the 5-year anniversary of FDA approval of Qelbree, a novel non-stimulant ADHD medication approved for children and adults. Qelbree has filled approximately 3 million prescriptions since launch and offers a unique pharmacodynamic profile targeting norepinephrine and serotonin receptors. The drug's safety, efficacy…